Screener
Rhythm Pharmaceuticals, Inc. RYTM Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | Three months ended March 31, 2026 | 2025 |
|---|---|---|
| Other income (expense): | ||
| Other income (expense), net | (1,704) | (644) |
| Interest expense | (4,583) | (5,409) |
| Interest income | 3,554 | 3,639 |
| Total other income (expense), net | (2,733) | (2,414) |
| Loss before income taxes | (55,094) | (49,418) |
| Provision for income taxes | 545 | 80 |
| Net loss | $(55,639) | $(49,498) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s interest income?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported interest income of $3.55M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s interest income changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s interest income decreased by 2.3% year-over-year, from $3.64M to $3.55M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s interest income?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s interest income has grown at a 141.9% compound annual growth rate (CAGR), from $447K to $15.29M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude